share_icon

If you need to inquire about Bayer product, please contact us through the following telephone:


Hotline: 400-810-0360 (available by mobile or telephone)


We will try our best to provide you the information about Bayer products, but we can't propose any specific diagnosis and treatment suggestions for patients' conditions. If you have any discomfort after medication, please go to see your doctor and receive timely medical treatment.


If you want to report a side effect or quality complaint, please contact your health care professional (e.g. treating physician or pharmacist) or your local health authority, Inquiries can also be directed to:


Email:AE_China@bayer.com


If you observe adverse event after Bayer Animal Health product application, you can transfer the information to us directly by:


Email:pv.bsah@bayer.com

To ask other question about Bayer China, please send e-mail to webmaster.china@bayer.com .


close
Bayer China
History
Bayer's links with Greater China go back to 1882, when it first began marketing dyes on the Chinese market. Since then, business in China has gone from strength to strength. Today, China is one of Bayer's main centers of global investment.
In the early years, Bayer relied on German trading houses and local trading organizations located in the treaty ports, who channeled Bayer products from central points into China's provinces. Later on, there were first attempts to establish independent companies in Shanghai, such as "Firma Friedrich Bayer & Co." in 1913, and "Bayer Pharma Co." in 1936. Bayer Pharma Co. also manufactured a range of products for China, among them the famous Aspirin pain reliever.
Bayer's renewed commitment to China after World War II culminated in the establishment of its independent trading entity Bayer China Co. Ltd. in Hong Kong, in 1958. The founding of this company once again allowed Bayer to organize its business in China effectively, a business that grew steadily over the decades that followed. In 1986, this hard work was rewarded with the establishment of a representative office and a liaison office in Beijing and Shanghai, respectively.
The signing of a broadly based cooperation agreement between Bayer and the Ministry for Chemical Industry in 1993 laid the foundations for expanding the business activities in China. A year later, Bayer (China) Ltd. was established as a holding company in Beijing to coordinate technology transfer and market development and support the preparation and implementation of joint venture projects. Step-by-step investment in a number of production facilities followed, in line with China's economic development.
Bayer's investment strategy in China entered a new phase in 2001, when then Chinese Premier Zhu Rongji and German Chancellor Gerhard Schroeder, along with the Chairman of the Board of Bayer Dr. Manfred Schneider, marked the groundbreaking for Bayer's Integrated Polymers Site at the Shanghai Chemical Industry Park.
Milestones
1882 Textile dyes first sold in China
1913 Founding of the trading company: Fr. Bayer Co. in Shanghai
1936 Aspirin production at Bayer Pharma Co., Shanghai
1994 Founding of Bayer China Holding Company
1995-1997 Founding of 12 small and mid- size JVs for different businesses; Construction of pharmaceutical facility for Bayer HealthCare
2001 Groundbreaking for Bayer Integrated Site, Shanghai Bayer Crop Science China Hangzhou production site put into operation
2004 Lanxess carve-out
2005 Acquisition of Roche Consumer Health
2008 Acquisition of OTC brand portfolio from Sagmel (CEE) and Topsun (China)
2009 Set-up of global pharmaceutical R&D center in Beijing
2012 Global headquarters for Polycarbonates* business in China Bayer celebrates its 130th anniversary in China
2014 Start of Bayer HealthCare Beijing Site Expansion Acquisition of Dihon and Merck’s OTC business
2015 Covestro* carve-out
2016 Inaugurated the EUR 100 million extension program of Pharmaceuticals Product Supply Beijing Site
2018 Bayer closes Monsanto acquisition (completed the acquisition on June 7)
Search
Follow Us
Last updated:2019-09-09
Top
Bayer China -History


Seite verkleinern Normalansicht Seite vergrößern

History

Bayer's links with Greater China go back to 1882, when it first began marketing dyes on the Chinese market. Since then, business in China has gone from strength to strength. Today, the People's Republic of China is one of Bayer's main centers of global investment.

In the early years, Bayer relied on German trading houses and local trading organizations located in the treaty ports, who channeled Bayer products from central points into China's provinces. Later on, there were first attempts to establish independent companies in Shanghai, such as "Firma Friedrich Bayer & Co." in 1913, and "Bayer Pharma Co." in 1936. Bayer Pharma Co. also manufactured a range of products for China, among them the famous Aspirin pain reliever.

Bayer's renewed commitment to China after World War II culminated in the establishment of its independent trading entity Bayer China Co. Ltd. in Hong Kong, in 1958. The founding of this company once again allowed Bayer to organize its business in China effectively, a business that grew steadily over the decades that followed. In 1986, this hard work was rewarded with the establishment of a representative office and a liaison office in Beijing and Shanghai, respectively.

The signing of a broadly based cooperation agreement between Bayer and the Ministry for Chemical Industry in 1993 laid the foundations for expanding the business activities in China. A year later, Bayer (China) Ltd. was established as a holding company in Beijing to coordinate technology transfer and market development and support the preparation and implementation of joint venture projects. Step-by-step investment in a number of production facilities followed, in line with China's economic development.

Bayer's investment strategy in China entered a new phase in 2001, when then Chinese Premier Zhu Rongji and German Chancellor Gerhard Schroeder, along with the Chairman of the Board of Bayer Dr. Manfred Schneider, marked the groundbreaking for Bayer's Integrated Polymers Site at the Shanghai Chemical Industry Park.

Milestones


1882 First sales of textile dyes

1913 Founding of the trading company Fr. Bayer Co. in Shanghai

1936 “Aspirin“ production at Bayer Pharma Co., Shanghai

1958 Establishment of Bayer China Ltd., Hong Kong

1984 Import business by Bayer China Co., Ltd., (Hong Kong)

1989 The 1st agrochemical JV company established in Tianjin by the former Aventis company, which is now part of Bayer CropScience

1994 Entry of Bayer as an investor in China; Bayer (China) Ltd. set up as holding company

1996 Bayer HealthCare starts construction of pharmaceutical manufacturing facility

1996 Bayer MaterialScience operates the joint venture company Bayer Guangyi Panel Co.Ltd., set up in Beijing

1997 Bayer (Sichuan) Animal Health Co. Ltd., starts operations in Chengdu

1999 Bayer Jinling Polyurethane Co. Ltd. comes on stream in Nanjing

2000 Bayer CropScience (China) Company Limited is established

2001 Groundbreaking for Bayer’s Integrated Site Shanghai

2001 Bayer Polymers (Shanghai) Co. Ltd. is founded

2001 Sighs research cooperation agreement with the Chinese Academy of Sciences

2002 Bayer and Aventis CropScience business merges under a new name as Bayer CropScience

2002 Signs agreement with the Shanghai Petrochemical Academy (SPA) to cooperate to train skilled chemical workers in Shanghai

2002 Establishes partnership with Special Olympics and adopts three special schools in Beijing and Shanghai

2002 Establishes partnership with Mercy Corps and China Foundation for Poverty Alleviation to provide micro lending and skills training to farmers in poverty-stricken areas of China

2003 Bayer (Shanghai) Polyurethanes Co. Ltd is established

2003 Bayer Technology and Engineering (Shanghai) Co. Ltd. is established

2003 Bayer Young Environmental Envoy, Bayer’s global partnership program with United Nations Environmental Programme, is established in China

Bayer Environmental Award for Media program is established

2004 Tsinghua-Bayer Public Health and HIV/AIDS Media Studies Program

2004 Bayer-Tongji Chair for Intellectual Property Rights is established

2005 Founding of Bayer MaterialScience Trading (Shanghai) Co. Ltd

2005 Bayer HealthCare successfully acquires Roche OTC business

2006 Bayer CropScience first launches its innovative fungicide – Infinito in China

2007 Bayer HealthCare and Schering Pharmaceuticals complete merger with the new name Bayer Schering Pharma

2007 Bayer-Tongji Chair for Sustainable Development is established

2007 CEIBS Research Centre is established for Health Care Policy and Management

2007 Bayer actively supports the 2007 Special Olympics World Summer Games

2007 Bayer receives awards including Honorary Credential of China Foundation for Poverty Alleviation; Award for Outstanding Performance in CSR; Special Olympics Contribution Certificate; Multinational Corporation with Utmost Core Competitiveness in China; One of Top Employers in Shanghai Region, etc.

2008 Groundbreaking for BaySystems

2008 Bayer Healthcare Topsun acquisition

2008 Bayer MaterialScience MDI Opening Ceremony and TDI Ground Breaking

2009 Bayer Schering Pharma-100 million Euro investment for global scale R&D center in Beijing, China

2010 Additional Investments of around EUR 1 billion for Bayer Integrated Site Shanghai are planned for expanding its capacities in the upcoming years. Total investment reached to over Euro 3 billion. Bayer becomes largest foreign investor in Shanghai

2011 Polycarbonates global headquarters was relocated from the main Leverkusen site to Shanghai and Bayer aims to increase the sales in Greater China to around EUR 6 billion by 2015
  • Share to:
Search
Follow Us
BayerChina_History